Literature DB >> 29888405

Real-life effectiveness of biological drugs on psoriatic difficult-to-treat body regions: scalp, palmoplantar area and lower limbs.

M Megna1, T Cirillo1, A Balato1, N Balato2, L Gallo1.   

Abstract

Entities:  

Year:  2018        PMID： 29888405     DOI： 10.1111/jdv.15119

Source DB:  PubMed          Journal:  J Eur Acad Dermatol Venereol        ISSN： 0926-9959            Impact factor:   6.166


× No keyword cloud information.
  2 in total

1.  Risankizumab treatment in psoriasis patients who failed anti-IL17: A 52-week real-life study.

Authors:  Matteo Megna; Luca Potestio; Angelo Ruggiero; Elisa Camela; Gabriella Fabbrocini
Journal:  Dermatol Ther       Date:  2022-04-26       Impact factor: 3.858

2.  Ixekizumab in scalp psoriasis: Clinical, dermoscopical, and in vivo reflectance confocal microscopy evaluation.

Authors:  Sonia Sofia Ocampo-Garza; Alessia Villani; Eleonora Cinelli; Elisa Camela; Gabriella Fabbrocini; Matteo Megna
Journal:  Dermatol Ther       Date:  2022-02-03       Impact factor: 3.858
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.